期刊文献+

利钠肽家族及其与心力衰竭的关系 被引量:1

Natriuretic peptide family and its relationship with heart failure
下载PDF
导出
摘要 利钠肽家族作为内分泌激素,主要包括心房钠尿肽、脑钠肽、C型利钠肽及D型利钠肽,通过利钠、利尿、舒张血管及对抗肾素-血管紧张素-醛固酮系统等途径在调节血容量、血管弹性、血压等方面发挥重要的作用。对利钠肽(尤其是脑钠肽)的研究表明,心力衰竭等心脏病患者血浆利钠肽水平升高,升高的利钠肽提示心血管事件的高危险性,监测血浆利钠肽有助于心力衰竭的诊断、治疗指导和预后评估。本文就利钠肽家族及其与心力衰竭的关系做一综述。 The natriuretic peptide family as endocrine hormones, including atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C type natriuretic peptide (CNP) and D type natriuretic peptide (DNP), play a signifi-cant role in regulating blood volume, blood pressure, blood vessel elasticity through natriuresis, diuresis, vasodilata-tion and antagonism of the rennin-angiotensin-aldosterone system. Researches showed that the natriuretic peptide (es-pecially the BNP) in plasma was elevated in patients with heart failure (HF) or heart disease, and the elevated natriuret-ic peptide suggested high risk for cardiovascular events. The monitoring of natriuretic peptide is helpful for the diagno-sis, guidance of treatment and prognosis in HF. Here is to make a commentary of the relationship between natriuretic peptide family and HF.
作者 韩曼 于远望
出处 《海南医学》 CAS 2015年第17期2558-2561,共4页 Hainan Medical Journal
基金 陕西省中医管理局中医药科研项目(编号:13-LC066 13LC061)
关键词 利钠肽 心力衰竭 关系 Natriuretic peptide Heart failure Relationship
  • 相关文献

参考文献32

  • 1de Bold AJ, Borenstein HB, Veress AT, et al. Arapid and potent natri- uretie response to intravenous injection of atrial myocardial extract in rats [J]. Life Sci, 1981, 28(1): 89-94. 被引量:1
  • 2Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain [J]. Nature, 1988, 332(6159): 78-81. 被引量:1
  • 3Saito Y, Nakao K, Itoh H, et al. Brain natriuretic peptide is a novelcardiac hormone [J]. Biochem Biophys Res Commun, 1989, 158 (2): 360-368. 被引量:1
  • 4Sudoh T, Minamino N, Kangawa K, et aL C-typenatriuretic peptide (CNP): a new member of the natriuretic peptide family identified in porcine brain [J]. Biochem Biophys Res Commun, 1990, 168(2): 863-870. 被引量:1
  • 5Goetze JP, Hausen LH, Terzic D, et al. Atrial natrinretic peptides in plasma [J]. Clin Chim Acta, 2015, 443: 25-28. 被引量:1
  • 6Mohammed AA, Januzzi JL Jr. Natriuretic peptide guided heart fail- ure management [J]. Curr Clin Pharmacol, 2009, 4: 87-94. 被引量:1
  • 7Stryjewski PJ, Nessler B, Cubera K, et al. Natriuretic peptides. His- tory of discovery, chemical structure, mechanism of action and the removal routes. Basis of diagnostic and therapeutic use [J]. Przegl Lek, 2013, 70(7): 463-467. 被引量:1
  • 8Takushima S, Nishi Y, Nonoshita A, et al. Changes in the nitric ox- ide-soluble guanylate cyclase system and natriuretic peptide recep- tor system in placentas of pregnant Dalai salt-sensitive rats [Y]. J Ob- stet Gynaecol Res, 2015, 41(4): 540-550. 被引量:1
  • 9Park BM, Oh YB, Gao S, et al. Angioteusin III stimulates high stretch-induced ANP secretion via angiotensin type 2 receptor [J]. Pepfides, 2013, 42: 131-137. 被引量:1
  • 10Vodovar N, Stronde MF, Laribi S, et al. Post-translational modifica- tions enhance NT-proBNP and BNP production in acute deeompen- sated heart failure [J]. Eur Heart J, 2014, 35(48): 3434-3441. 被引量:1

二级参考文献43

  • 1Adams KF, Lindenfeld J, Arnold JMO, et al. Executive summary:HFSA 2006 comprehensive heart failure practice guideline[J]. J Card Fail, 2006, 12:10-38. 被引量:1
  • 2Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guide-line update for the diagnosis and management of chronic heart failure in the adult: a report of the American college of cardiology/American heart association task force on practice guide-lines [J]. Circulation, 2005, 112:e154-e235. 被引量:1
  • 3Lee DS, Austin PC, Rouleau JL,et al. Predicting mortality among patients hospitalized for or heart failure: derivation and validation of a clinical model[J]. J Am Med Assoc,2003, 290:2581-2587. 被引量:1
  • 4Mohammed AA, Januzzi JL, Jr. Natriuretic peptide guided heart failure management[J]. Curr Clin Pharmacol, 2009, 4:87-94. 被引量:1
  • 5Cowie MR, Struthers AD, Wood DA, et al. Value ofnatriuretic peptides in assessment of patients with possible new heart failure in primary care[J]. Lancet, 1997, 350:1347-1351. 被引量:1
  • 6Braunwald E. Biomarkers in heart failure [J]. NEJM, 2008, 358:2148 -2159. 被引量:1
  • 7Baggish AL, Kimmenade RR, Januzzi JL. Amino-terminal Pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure [J]. Am J Cardiol, 2008, 101 (suppl):49-55. 被引量:1
  • 8Braunschweig F, Fahrleitner-Pammer A, Mangiavacchi M, et al. Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure[J]. Eur J Heart Fail, 2006, 8:797-803. 被引量:1
  • 9Troughton RW, Richards AM. Outpatient monitoring and treatment of chronic heart failure guided by amino-terminal Pro-B-type natriuretic peptide measurement[J]. Am J Cardiol, 2008,101 (suppl):72A-75A. 被引量:1
  • 10Davis ME, Richards AM, Nicholls MG, et al. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure[J]. Circulation, 2006, 113:977-985. 被引量:1

共引文献19

同被引文献6

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部